Seramune Oral

This page contains information on Seramune Oral for veterinary use.
The information provided typically includes the following:
  • Seramune Oral Indications
  • Warnings and cautions for Seramune Oral
  • Direction and dosage information for Seramune Oral

Seramune Oral

This treatment applies to the following species:
Manufacturer: Sera

For Failure of Passive Transfer in Neonatal Foals

Bottle contains one dose of 300ml.

Dose: Administer orally in two even amounts (150 mL each) 1-2 hours apart, within first 12 hours of life.

Protect from direct sunlight. Store refrigerated at 2°-7°C/36°-45°F. Do not freeze. Once opened, use entire contents as directed above.

Equine serum origin.

For use by or under the direction of a veterinarian.

Seramune Oral Indications

For the treatment of failure of passive transfer in neonatal foals.

Seramune Oral Caution

As with any serum product, adverse reactions may occur. In case of reactions, stop treatment and administer epinephrine.

U.S. Vet. Lic. No. 328

300ml

Sera, Inc., P.O. Box 15866, Shawnee Mission, Kansas, 66285-5866

NAC No.: 14980011

SERA, INC.
P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866
Telephone:   913-541-1307
Toll-Free:   800-552-3984
Fax:   913-541-1712
Website:   www.seramune.com
Email:   sera@everestkc.net
Every effort has been made to ensure the accuracy of the Seramune Oral information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-04-11

(web4)